Return to the catalog
TB-500
PopularIn Stock5mg vial

TB-500

Thymosin beta-4 fragment studied for cell movement, blood vessels, and tissue repair.

For Research Use Only

Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.

1–4 vialsR 550.00
5+ vials — save 27%R 400.00 each

The lower price is applied automatically once your cart holds 5 or more of this vial.

Bacteriostatic water included

99%+ Purity
Extensively Researched
1

About this peptide

TB-500 is a laboratory-made fragment based on an active region of thymosin beta-4, a naturally occurring protein involved in tissue maintenance. Researchers study how it affects cell movement, new blood-vessel formation, and inflammatory signalling. Most evidence comes from laboratory and animal tissue-repair models.

Why researchers reach for TB-500

Cell motility

Actin-sequestering behavior referenced in migration assays.

Vascular remodeling

Angiogenesis literature across cardiac and dermal models.

Inflammation resolution

Referenced in cytokine-modulation and fibrosis studies.

Key features

  • ≥99% HPLC purity
  • Truncated Tβ4 active fragment
  • Mass-spec verified
  • Cold-chain dispatch

How it works

Actin binding

Reversibly sequesters G-actin monomers to modulate cytoskeletal dynamics.

Endothelial signaling

Upregulates VEGF and related angiogenic markers in vitro.

Anti-fibrotic profile

Reduces TGF-β driven fibrosis in animal cardiac models.

Research dosage guidelines

Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.

RangeReported doseNote
Typical reconstitution2 mL bacteriostatic waterYields 2.5 mg/mL (2500 mcg/mL)
Reported research range1–5 mg/week (split)Reference only

Tracking this compound? Registered researchers can log active TB-500 protocols in their private Research Log.

Timing in research protocols

No published human timing data.

  • No human pharmacokinetic or dose-finding trial for TB-500 has been published.
  • Native thymosin beta-4 shows a short plasma half-life in early intravenous reports; longer 'tissue half-life' claims for TB-500 are not peer-reviewed.
  • Weekly loading-then-maintenance schedules in circulation come from non-clinical sources.
  • No credible time-of-day or meal-timing evidence exists.

Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.

Technical specifications

Sequence
Ac-LKKTETQ (Tβ4 17-23 fragment)
Molecular weight
889.05 g/mol
Purity
≥99% (HPLC)
Form
Lyophilized powder
Vial size
5 mg
Storage (lyophilised vial)
Cool, dry and protected from light
Storage (after reconstitution)
2–8°C

Published research

Peer-reviewed literature on TB-500. Links open in a new tab.

Research use notice

Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.

#recovery#angiogenesis#cytoskeleton

Cart (0)

Your cart is empty